Involvement of vasoactive intestinal peptide on insulin-like growth factor I-Induced proliferation of rat pituitary lactotropes in primary culture:: Evidence for an autocrine and/or paracrine regulatory system

被引:19
作者
Fernández, M
Sánchez-Franco, F
Palacios, N
Sánchez, I
Villuendas, G
Cacicedo, L
机构
[1] Hosp Ramon & Cajal, Serv Endocrinol, E-28034 Madrid, Spain
[2] Hosp Carlos 3, CIC, Serv Endocrinol, Inst Salud Carlos III, Madrid, Spain
关键词
insulin-like growth factors; vasoactive intestinal peptide; lactotropes; protein kinases; cell proliferation;
D O I
10.1159/000070900
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
In previous studies we demonstrated that insulin-like growth factor I (IGF-1) induces pituitary vasoactive intestinal peptide (VIP) gene expression and secretion, and that IGF-1-induced prolactin (PRL) release is mediated by VIP. In this study, we investigate the mitotropic action of IGF-1 and VIP on pituitary lactotropes, and their possible interplay in this effect. Cultured male rat pituitary cells were treated with rhIGF-1 (10(-7) M) and/or VIP (10-7 M) for 48 h. 5-Bromo-2'-deoxyuridine (BrdU) (10 muM) was added for labeling proliferation of pituitary cells. BrdU-labeling indices indicative of the proliferation rate of lactotropes were determined by double-labeling immunofluorescence staining for PRL and BrdU. Treatment with either IGF-1 or VIP increased BrdU-labeling indices of lactotropes, but there was no further increase upon combined incubation with both factors, suggesting an interaction between the signal transduction pathways of IGF-I and VIP. VIP antiserum partially suppressed IGF-I-induced BrdU-labeling indices of lactotropes. We also investigated the intracellular signal transduction pathways in the action of IGF-I and VIP on the proliferation of lactotropes. Treatment of pituitary cells with an inhibitor of the mitogen-activated protein kinase (MAPK) pathway completely abolished IGF-I-induced lactotrope proliferation, whereas it partially suppressed VIP-induced BrdU-labeling indices. The protein kinase A (PKA) inhibitor, which abolished the mitogenic action of VIP, markedly suppressed IGF-I-induced lactotrope proliferation. These results indicate that both IGF-I and VIP stimulate lactotrope proliferation, and that IGF-I-induced lactotrope proliferation is partially mediated by VIP produced locally. Also, this study suggests that interactions between MAPK and cyclic adenosine 3',5'-monophosphate-PKA signaling pathways are implicated in the lactotrope proliferation induced by IGF-I and VIP. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:341 / 352
页数:12
相关论文
共 64 条
[1]
VASOACTIVE INTESTINAL PEPTIDE IS A PHYSIOLOGICAL MEDIATOR OF PROLACTIN-RELEASE IN THE RAT [J].
ABE, H ;
ENGLER, D ;
MOLITCH, ME ;
BOLLINGERGRUBER, J ;
REICHLIN, S .
ENDOCRINOLOGY, 1985, 116 (04) :1383-1390
[2]
PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[3]
REGULATORY ACTIVITY AND TOPOLOGICAL DISTRIBUTION OF FOLLICULO-STELLATE CELLS IN RAT ANTERIOR-PITUITARY CELL AGGREGATES [J].
ALLAERTS, W ;
DENEF, C .
NEUROENDOCRINOLOGY, 1989, 49 (04) :409-&
[4]
D2 dopamine-receptor-mediated inhibition of proliferation of rat lactotropes in culture is accompanied by changes in cell shape [J].
Arita, J ;
Hashi, A ;
Hoshi, K ;
Mazawa, S ;
Suzuki, S .
NEUROENDOCRINOLOGY, 1998, 68 (03) :163-171
[5]
VASOACTIVE INTESTINAL POLYPEPTIDE IS SYNTHESIZED IN ANTERIOR-PITUITARY TISSUE [J].
ARNAOUT, MA ;
GARTHWAITE, TL ;
MARTINSON, DR ;
HAGEN, TC .
ENDOCRINOLOGY, 1986, 119 (05) :2052-2057
[6]
DIFFERENTIAL-EFFECTS OF INSULIN-LIKE GROWTH FACTOR-I ON THE HORMONAL PRODUCT AND PROLIFERATION OF GLYCOPROTEIN-SECRETING HUMAN PITUITARY-ADENOMAS [J].
ATKIN, SL ;
LANDOLT, AM ;
JEFFREYS, RV ;
HIPKIN, L ;
RADCLIFFE, J ;
SQUIRE, CR ;
WHITE, MC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (04) :1059-1066
[7]
ANATOMY OF THE PITUITARY INSULIN-LIKE GROWTH-FACTOR SYSTEM [J].
BACH, MA .
ENDOCRINOLOGY, 1992, 131 (06) :2588-2594
[8]
Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion [J].
Balsa, JA ;
SanchezFranco, F ;
Lorenzo, MJ ;
Pazos, F ;
Lara, JI ;
Cacicedo, L .
ENDOCRINOLOGY, 1996, 137 (02) :508-513
[9]
DIRECT ACTION OF OPIOID-PEPTIDES AND NALOXONE ON GONADOTROPIN-SECRETION BY CULTURED RAT ANTERIOR-PITUITARY-CELLS [J].
CACICEDO, L ;
FRANCO, FS .
LIFE SCIENCES, 1986, 38 (07) :617-625
[10]
CAMPBELL JS, 1995, RECENT PROG HORM RES, V50, P131